ARCHIVES

St. John’s Wort Not Indicated For Patients On Irinotecan

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

High Risk workshop Planned To Produce Monograph On Current Knowledge

October 11, 1974

TA To Release Report On Burton Therapy Requested By Congress

February 9, 1990

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

Pat Barr, Early NBCC Activist, Dead.

June 27, 2003